Sex based analysis of the impact of red blood cell transfusion and vascular or bleeding complications related to TAVI - The TRITAVI-Women Study.
暂无分享,去创建一个
M. Niemelä | J. Airaksinen | D. Capodanno | G. Stefanini | F. Radico | M. Zimarino | Tania Rodríguez-Gabella | F. Biancari | A. Picchi | S. Gallina | M. Eskola | I. Amat-Santos | C. Tamburino | F. Bedogni | M. Barbanti | L. Testa | F. Saia | B. Reimers | C. Moretti | E. Nicolini | N. Maddestra | P. Raivio | T. Piva | F. Fabbiocchi | A. Valtola | P. Olivares
[1] M. Niemelä,et al. Blood Transfusion and Outcome After Transfemoral Transcatheter Aortic Valve Replacement. , 2019, Journal of cardiothoracic and vascular anesthesia.
[2] A. Sannino,et al. Comparison of Baseline Characteristics and Outcomes in Men Versus Women With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. , 2018, The American journal of cardiology.
[3] S. Bagshaw,et al. Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery , 2017, The New England journal of medicine.
[4] F. Mohr,et al. Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI). , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] J. Webb,et al. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial. , 2017, JACC. Cardiovascular interventions.
[6] A. Regueiro,et al. Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] D. Sorysz,et al. Association Between Blood Transfusions and 12-Month Mortality After Transcatheter Aortic Valve Implantation. , 2017, International heart journal.
[8] G. Dangas,et al. Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. , 2016, Journal of the American College of Cardiology.
[9] A. Pichard,et al. Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. , 2016, The American journal of cardiology.
[10] Y. Arbel,et al. Impact of Hemoglobin Drop, Bleeding Events, and Red Blood Cell Transfusions on Long-term Mortality in Patients Undergoing Transaortic Valve Implantation. , 2016, The Canadian journal of cardiology.
[11] Samin K. Sharma,et al. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. , 2016, JACC. Cardiovascular interventions.
[12] M. Mack,et al. Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement , 2016, Annals of Internal Medicine.
[13] M. Leon,et al. Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients. , 2015, Journal of the American College of Cardiology.
[14] L. Pierelli,et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single‐blind randomized controlled trial , 2015, Transfusion.
[15] M. Mack,et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. , 2014, Journal of the American College of Cardiology.
[16] F. Santini,et al. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. , 2014, The Journal of thoracic and cardiovascular surgery.
[17] J. Maessen,et al. Prevalence, Factors Associated With, and Prognostic Effects of Preoperative Anemia on Short- and Long-Term Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation , 2013, Circulation. Cardiovascular interventions.
[18] J. Bavaria,et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. , 2012, Journal of the American College of Cardiology.
[19] P. Serruys,et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. , 2012, American heart journal.
[20] Y. Yoo,et al. Effect of Single Recombinant Human Erythropoietin Injection on Transfusion Requirements in Preoperatively Anemic Patients Undergoing Valvular Heart Surgery , 2011, Anesthesiology.
[21] P. Serruys,et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[22] H. Baumgartner,et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis , 2010, Heart.
[23] F. Crea,et al. Sex-related differences in myocardial remodeling. , 2010, Journal of the American College of Cardiology.
[24] Meng Xu,et al. The Impact of Gender on In-Hospital Mortality and Morbidity After Isolated Aortic Valve Replacement , 2006, Anesthesia and analgesia.
[25] Philippe Ravaud,et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.
[26] T. Yamada,et al. Autologous blood donation with recombinant human erythropoietin in anemic patients. , 1999, The Annals of thoracic surgery.